291 related articles for article (PubMed ID: 12494472)
21. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
[TBL] [Abstract][Full Text] [Related]
23. Serum IL-6 and IL-12 levels in breast cancer patients.
Hussein MZ; Al Fikky A; Abdel Bar I; Attia O
Egypt J Immunol; 2004; 11(2):165-70. PubMed ID: 16734129
[TBL] [Abstract][Full Text] [Related]
24. The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.
George DJ; Halabi S; Shepard TF; Sanford B; Vogelzang NJ; Small EJ; Kantoff PW
Clin Cancer Res; 2005 Mar; 11(5):1815-20. PubMed ID: 15756004
[TBL] [Abstract][Full Text] [Related]
25. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease.
Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L
Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643
[TBL] [Abstract][Full Text] [Related]
26. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy.
Bozcuk H; Uslu G; Samur M; Yildiz M; Ozben T; Ozdoğan M; Artaç M; Altunbaş H; Akan I; Savaş B
Cytokine; 2004 Jul 21-Aug 7; 27(2-3):58-65. PubMed ID: 15242694
[TBL] [Abstract][Full Text] [Related]
27. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis.
Zhang GJ; Adachi I
Int J Oncol; 1999 Jan; 14(1):71-7. PubMed ID: 9863011
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of circulating interleukin-23 as a prognostic factor in breast cancer patients.
Gangemi S; Minciullo P; Adamo B; Franchina T; Ricciardi GR; Ferraro M; Briguglio R; Toscano G; Saitta S; Adamo V
J Cell Biochem; 2012 Jun; 113(6):2122-5. PubMed ID: 22298331
[TBL] [Abstract][Full Text] [Related]
29. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
30. The influence of basal phenotype on the metastatic pattern of breast cancer.
Luck AA; Evans AJ; Green AR; Rakha EA; Paish C; Ellis IO
Clin Oncol (R Coll Radiol); 2008 Feb; 20(1):40-5. PubMed ID: 17981444
[TBL] [Abstract][Full Text] [Related]
31. [PTHrP and bone sialoprotein as prognostic markers for developing bone metastases in breast cancer patients].
Loibl S; Königs A; Kaufmann M; Costa SD; Bischoff J
Zentralbl Gynakol; 2006 Dec; 128(6):330-5. PubMed ID: 17213971
[TBL] [Abstract][Full Text] [Related]
32. Serum sonic hedgehog (SHH) and interleukin-(IL-6) as dual prognostic biomarkers in progressive metastatic breast cancer.
Noman AS; Uddin M; Chowdhury AA; Nayeem MJ; Raihan Z; Rashid MI; Azad AK; Rahman ML; Barua D; Sultana A; Shirin A; Ferdous J; Parag RR; Rahman SM; Mahmud MR; Jerin CS; Jahan N; Siddiqua A; Ara T; Sabur EB; Alam SS; Baidya S; Akther S; Rahman MZ; Banu T; Murugan AK; Sabri S; Islam SMS; Karakas B; Aboussekhra A; Yeger H; Farhat WA; Islam SS
Sci Rep; 2017 May; 7(1):1796. PubMed ID: 28496132
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity.
Domingo-Domenech J; Oliva C; Rovira A; Codony-Servat J; Bosch M; Filella X; Montagut C; Tapia M; Campás C; Dang L; Rolfe M; Ross JS; Gascon P; Albanell J; Mellado B
Clin Cancer Res; 2006 Sep; 12(18):5578-86. PubMed ID: 17000695
[TBL] [Abstract][Full Text] [Related]
34. Distant metastasis in triple-negative breast cancer.
Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF
Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998
[TBL] [Abstract][Full Text] [Related]
35. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis.
Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R
Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319
[TBL] [Abstract][Full Text] [Related]
36. Reduction in serum IL-6 after vacination of breast cancer patients with tumour-associated antigens is related to estrogen receptor status.
Jiang XP; Yang DC; Elliott RL; Head JF
Cytokine; 2000 May; 12(5):458-65. PubMed ID: 10857759
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in 401 elderly women with metastatic breast cancer.
Follana P; Barrière J; Chamorey E; Largillier R; Dadone B; Mari V; Hannoun-Levi JM; Marcy M; Flipo B; Ferrero JM
Oncology; 2014; 86(3):143-51. PubMed ID: 24577186
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
39. Elevated levels of serum tumor markers CA 15-3 and CEA are prognostic factors for diagnosis of metastatic breast cancers.
Lee JS; Park S; Park JM; Cho JH; Kim SI; Park BW
Breast Cancer Res Treat; 2013 Oct; 141(3):477-84. PubMed ID: 24072270
[TBL] [Abstract][Full Text] [Related]
40. The value of serum S-100beta and interleukins as tumour markers in advanced melanoma.
Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E
Melanoma Res; 2000 Jun; 10(3):237-41. PubMed ID: 10890377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
